ArticleClinical pharmacology and therapeutics2021

Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.

Craig R Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.